hVIVO's Mo Khan on the company’s breakthrough year

25 January 2023 - 11:36
Vox Markets speaks to Mo Khan, chief executive of fast-growing clinical research specialist hVIVO, about the factors behind an expectation-beating year, and how rising awareness of its unique human challenge model points to major growth ahead....
London AIM (United Kingdom)
Euronext Growth Dublin (Ireland)
hVIVO is a pharmaceutical service/contract research company that is a leader in testing vaccines and antivirals using human challenge clinical trials. The Company provides services to Big Pharma, biotech and government/public health organisations....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More